Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Men with testicular cancer were less likely to experience baldness and severe acne.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Finasteride doesn't affect hormone levels in normal men.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The normal human prostate does not significantly affect blood DHT levels.

New compounds may soon be tested to treat excessive hair growth in women.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Testosterone improves mood and thinking skills; finasteride has no effect.

Treatment during development affects hormone balance and sexual behavior in male rats.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Male hormones worsen kidney transplant damage, but blocking them helps.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Finasteride blocks progesterone's effect on absence seizures in rats.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Finasteride use can cause depression-like behavior in male rats.